Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Daiichi Sankyo initiates phase 2 study of patritumab deruxtecan in advanced colorectal cancer
Daiichi Sankyo initiates phase 2 study of patritumab deruxtecan in advanced colorectal cancer. (Credit: PublicDomainPictures from Pixabay)
Daiichi Sankyo initiates phase 2 study of patritumab deruxtecan in advanced colorectal cancer. (Credit: PublicDomainPictures from Pixabay)